BioSpace News Archive

Able Medical Devices, Inc. (Able) today announced the U.S. FDA 510(k) clearance of the Valkyrie™ Thoracic Fixation System. Valkyrie is intended for use in the stabilization and fixation of fractures of the chest wall, including sternal fixation following sternotomy, as well as sternal reconstructive surgical procedures

Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that John Celebi, President and Chief Executive Officer of Sensei Biotherapeutics, will present at the Oppenheimer 31 st Annual Virtual Healthcare Conference on Tuesday, March 16 th , 2021 at 9:20 a.m. ET.

Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category.

10x Genomics, Inc. announced expansion plans to support the company’s continued growth in Pleasanton across two properties.

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2020 financial results and provide a corporate update on Tuesday, March 16, 2021.

Brain Scientific Inc. (OTCQB: BRSF ), a neurology-focused medical device and software company, announced today it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation NeuroCap™ device. NeuroCap™ is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired.

Yew Bio-Pharm Group, Inc., a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle and soap made with yew essential oil in China, announced that it recently organized a new subsidiary in Guangzhou, China which focuses on yew related cosmetic product development, online sales and integrated marketing.

DECA Dental Group, a leading dental services organization, announced it has acquired Reign Dental, expanding the Company’s footprint into Washington state.

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Oppenheimer 31 st Annual Virtual Healthcare conference on Tuesday, March 16 - 17, 2021.

Results of new study from Mass General Hospital Cancer Center, Harvard Medical School, and Dana-Farber Cancer Institute underscore the need for the development and testing of nutrition and fitness interventions, as muscle quality significantly correlates with symptom burden, healthcare utilization, and survival.